Insider · CIK 0001553037

BRYCE RICHARD PAUL

Reports to the SEC for 3 companies · LOS ANGELES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001553037

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-30	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+153K sh	—	—	153,000
2023-02-15	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+110K sh	—	—	110,000
2022-01-07	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+53.1K sh	—	—	53,064
2021-04-05	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−426 sh	$9.80	−$4,176.035	121,662
2021-03-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−422 sh	$10.15	−$4,283.3	122,088
2021-02-17	PBYIPUMA BIOTECHNOLOGY, INC.A Award	SEE REMARKS	AAward	+52.8K sh	—	—	122,510
2021-02-17	PBYIPUMA BIOTECHNOLOGY, INC. · STOCK OPTION (RIGHT TO BUY)A Award	SEE REMARKS	AAward	+74.3K sh	—	—	74,341
2021-02-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−415 sh	$12.23	−$5,075.948	69,664
2021-01-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−6,548 sh	$10.23	−$67K	70,079
2020-12-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−92 sh	$11.65	−$1,071.8	76,627
2020-11-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−97 sh	$7.81	−$757.57	76,719
2020-10-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−91 sh	$10.14	−$923.104	76,816
2020-09-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−90 sh	$9.77	−$879.3	76,907
2020-08-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−86 sh	$10.80	−$928.8	76,997
2020-07-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−660 sh	$10.67	−$7,040.418	77,083
2020-06-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−89 sh	$10.66	−$948.74	77,743
2020-05-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−89 sh	$9.62	−$856.189	77,832
2020-04-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−91 sh	$7.37	−$670.679	77,921
2020-03-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−96 sh	$10.02	−$962.15	78,012
2020-02-11	PBYIPUMA BIOTECHNOLOGY, INC. · STOCK OPTION (RIGHT TO BUY)A Award	SEE REMARKS	AAward	+54.8K sh	—	—	54,842
2020-02-11	PBYIPUMA BIOTECHNOLOGY, INC.A Award	SEE REMARKS	AAward	+43.3K sh	—	—	78,108
2020-02-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−105 sh	$8.02	−$841.575	34,834
2020-01-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−2 sh	$8.36	−$16.72	36,453
2020-01-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−1,514 sh	$8.40	−$12.7K	34,939
2019-12-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−83 sh	$10.34	−$858.228	36,455
2019-11-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−88 sh	$7.38	−$649.449	36,538
2019-10-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−91 sh	$10.05	−$914.55	36,626
2019-09-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−95 sh	$10.11	−$960.45	36,717
2019-08-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−94 sh	$9.00	−$846	36,812
2019-07-22	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−1,841 sh	$10.10	−$18.6K	36,906
2019-07-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−89 sh	$12.78	−$1,137.42	38,747
2019-06-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−88 sh	$15.07	−$1,326.16	38,836
2019-05-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−85 sh	$32.38	−$2,752.309	38,924
2019-04-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−88 sh	$35.78	−$3,148.649	39,009
2019-03-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−88 sh	$38.66	−$3,402.08	39,097
2019-02-06	PBYIPUMA BIOTECHNOLOGY, INC. · STOCK OPTION (RIGHT TO BUY)A Award	SEE REMARKS	AAward	+15.4K sh	—	—	15,400
2019-02-06	PBYIPUMA BIOTECHNOLOGY, INC.A Award	SEE REMARKS	AAward	+9,900 sh	—	—	39,185
2019-02-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−89 sh	$27.77	−$2,471.53	29,285
2019-01-22	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−1,959 sh	$24.72	−$48.4K	29,374
2019-01-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−1,210 sh	$20.67	−$25K	31,333
2018-07-20	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−1,836 sh	$51.95	−$95.4K	32,543
2018-02-11	PBYIPUMA BIOTECHNOLOGY, INC. · STOCK OPTION (RIGHT TO BUY)A Award	SEE REMARKS	AAward	+14K sh	—	—	14,000
2018-02-11	PBYIPUMA BIOTECHNOLOGY, INC.A Award	SEE REMARKS	AAward	+9,000 sh	—	—	34,379
2018-02-11	PBYIPUMA BIOTECHNOLOGY, INC.A Award	SEE REMARKS	AAward	−9,000 sh	—	—	34,379
2018-01-22	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−1,860 sh	$92.75	−$173K	25,379
2017-09-29	PBYIPUMA BIOTECHNOLOGY, INC.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+15K sh	$11.30	+$170K	42,239
2017-09-29	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−15K sh	$120.00	−$1.8M	27,239
2017-09-29	PBYIPUMA BIOTECHNOLOGY, INC. · STOCK OPTION (RIGHT TO BUY)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−15K sh	—	—	67,000
2017-09-07	PBYIPUMA BIOTECHNOLOGY, INC. · STOCK OPTION (RIGHT TO BUY)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−14K sh	—	—	82,000
2017-09-07	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	SEE REMARKS	SSale	−14K sh	$100.10	−$1.4M	27,239

Recent filings

Accepted (ET)
Dec 44
BRYCE RICHARD PAUL0000929638-23-003341
SEC(opens sec.gov)
Feb 174
BRYCE RICHARD PAUL0001104659-23-023388
SEC(opens sec.gov)
Feb 44
BRYCE RICHARD PAUL0000899243-22-004836
SEC(opens sec.gov)
Apr 64
BRYCE RICHARD PAUL0001209191-21-025726
SEC(opens sec.gov)
Mar 44
BRYCE RICHARD PAUL0001209191-21-017836
SEC(opens sec.gov)
Feb 194
BRYCE RICHARD PAUL0001209191-21-012523
SEC(opens sec.gov)
Feb 34
BRYCE RICHARD PAUL0001209191-21-007534
SEC(opens sec.gov)
Jan 64
BRYCE RICHARD PAUL0001209191-21-002327
SEC(opens sec.gov)
Dec 44
BRYCE RICHARD PAUL0001209191-20-061811
SEC(opens sec.gov)
Nov 34
BRYCE RICHARD PAUL0001209191-20-056784
SEC(opens sec.gov)
Oct 54
BRYCE RICHARD PAUL0001209191-20-053766
SEC(opens sec.gov)
Sep 34
BRYCE RICHARD PAUL0001209191-20-049481
SEC(opens sec.gov)
Aug 54
BRYCE RICHARD PAUL0001209191-20-045120
SEC(opens sec.gov)
Jul 64
BRYCE RICHARD PAUL0001209191-20-041329
SEC(opens sec.gov)
Jun 34
BRYCE RICHARD PAUL0001209191-20-034136
SEC(opens sec.gov)
May 64
BRYCE RICHARD PAUL0001209191-20-027503
SEC(opens sec.gov)
Apr 34
BRYCE RICHARD PAUL0001209191-20-023194
SEC(opens sec.gov)
Mar 34
BRYCE RICHARD PAUL0001209191-20-015251
SEC(opens sec.gov)
Feb 134
BRYCE RICHARD PAUL0001209191-20-009445
SEC(opens sec.gov)

Companies

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 2150

LOS ANGELES, CA, 90024